DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Short Term Provisions History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Short Term Provisions | ₹931 Cr | ₹850 Cr | ₹527 Cr | ₹445 Cr | ₹1,265 Cr |
What is the latest Short Term Provisions ratio of DIVIS LABORATORIES ?
| Year | Short Term Provisions |
|---|---|
| Mar2026 | ₹931 Cr |
| Mar2025 | ₹850 Cr |
| Mar2024 | ₹527 Cr |
| Mar2023 | ₹445 Cr |
| Mar2022 | ₹1,265 Cr |
How is Short Term Provisions of DIVIS LABORATORIES Trending?
| Years | Short Term Provisions | % Change | |
|---|---|---|---|
| Mar2026 | ₹931 Cr | 9.53 | |
| Mar2025 | ₹850 Cr | 61.29 | |
| Mar2024 | ₹527 Cr | 18.43 | |
| Mar2023 | ₹445 Cr | -64.81 | |
| Mar2022 | ₹1,265 Cr | - | |
Compare Short Term Provisions of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹266,296.5 Cr | 5% | 7.2% | 49.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹425,150.0 Cr | 0.5% | -2.9% | 5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,300.0 Cr | -0.5% | -4.5% | 28.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,351.0 Cr | 2.7% | 8.4% | 5.1% | Stock Analytics | |
| CIPLA | ₹112,474.0 Cr | 2.4% | 2.4% | -12.9% | Stock Analytics | |
| MANKIND PHARMA | ₹102,315.0 Cr | -1.1% | -1.2% | 3.1% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 5% |
7.2% |
49.7% |
| SENSEX | 4.5% |
6.1% |
-9.3% |
You may also like the below Video Courses